☆ 4.6 Article

Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report

FRONTIERS IN NEUROSCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF A Retrospective Multicenter Study

Sara Carta et al.

Summary: This study aimed to investigate the clinical relevance of cerebrospinal fluid (CSF) myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) positivity. The findings suggest that CSF MOG-Abs positivity is associated with more severe clinical presentation and worse outcomes.

NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability

Young Nam Kwon et al.

Summary: The presence of CSF MOG-IgG improves the diagnosis of MOGAD in the absence of an MS phenotype, and intrathecal synthesis of MOG-IgG is associated with increased disability.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Add to Collection

Review Pediatrics

Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood

Aphra Luchesa Smith et al.

Summary: Pediatric-onset multiple sclerosis is the most common relapsing demyelinating syndrome in children, highlighting the importance of early recognition and referral to specialist services. New treatments aim to reduce relapses and disability, while a holistic approach to management is essential for supporting patients and families.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Add to Collection

Review Clinical Neurology

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

Elia Sechi et al.

Summary: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a recently defined inflammatory demyelinating disease of the central nervous system (CNS). The clinical and MRI features of MOGAD differ from other diseases such as AQP4-IgG+NMOSD and MS. MOG-IgG detection confirms the diagnosis, but false positive results are possible. International consensus diagnostic criteria are being compiled. Acute attacks of MOGAD are responsive to high dose steroids, and plasma exchange may be considered for refractory cases. More research is needed to guide attack-prevention and maintenance treatments.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Silent New Brain MRI Lesions in Children with MOG-Antibody Associated Disease

Giulia Fadda et al.

Summary: Research found that 14% of children with MOG-IgG antibodies had asymptomatic new brain lesions, but this does not necessarily indicate the need for immunotherapy. The detection of asymptomatic lesions in patients with this antibody has a low predictive value for clinically relapsing disease.

ANNALS OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care

Giulia Fadda et al.

Summary: The field of acquired CNS neuroimmune demyelination in children is undergoing significant transformation with the development of diagnostic criteria and therapeutic methods. The distinction between multiple sclerosis, MOGAD, and AQP4-NMOSD is becoming clearer, leading to potential breakthroughs in treatment.

LANCET NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

Patrick Waters et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Thais Armangue et al.

LANCET NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel H. Whittam et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Add to Collection

Correction Clinical Neurology

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligo-dendrocyte glycoprotein antibodies: a multicentre observational study (vol 19, pg 234, 2020)

T. Armangue et al.

LANCET NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Clinical Neurology

Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease

Yael Hacohen et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)

Add to Collection

Article Clinical Neurology

Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis

Luciana Midaglia et al.

REVISTA DE NEUROLOGIA (2018)

Add to Collection

Article Neurosciences

Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features

Silvia N. Tenembaum

NEUROIMAGING CLINICS OF NORTH AMERICA (2017)

Add to Collection

Article Clinical Neurology

Pediatric optic neuritis

E. Ann Yeh et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders

Eoin P. Flanagan et al.

JAMA NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features

Michael Absoud et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Add to Collection

Review Clinical Neurology

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

Lauren B. Krupp et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

Add to Collection

Article Pediatrics

Childhood optic neuritis clinical features and outcome

Michael Absoud et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.